Effects of 5 alpha-reductase inhibitor therapy with dutasteride on sexual function in patients with benign prostatic hyperplasia

dc.contributor.authors	Halis, F; Kumsar, S; Cimen, HI; Gokce, A;
dc.date.accessioned	2020-01-17T11:59:29Z
dc.date.available	2020-01-17T11:59:29Z
dc.date.issued	2019
dc.identifier.citation	Halis, F; Kumsar, S; Cimen, HI; Gokce, A; (2019). Effects of 5 alpha-reductase inhibitor therapy with dutasteride on sexual function in patients with benign prostatic hyperplasia. KUWAIT MEDICAL JOURNAL, 51, 144-140
dc.identifier.issn	0023-5776
dc.identifier.uri	https://hdl.handle.net/20.500.12619/7149
dc.description.abstract	Conclusion: Six-month therapy of dutasteride in men with BPH did not alter the sexual functions.
dc.language	English
dc.publisher	KUWAIT MEDICAL ASSOC
dc.subject	General & Internal Medicine
dc.title	Effects of 5 alpha-reductase inhibitor therapy with dutasteride on sexual function in patients with benign prostatic hyperplasia
dc.type	Article
dc.identifier.volume	51
dc.identifier.startpage	140
dc.identifier.endpage	144
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Cerrahi Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Gökçe, Ahmet
dc.relation.journal	KUWAIT MEDICAL JOURNAL
dc.identifier.wos	WOS:000488219700004
dc.contributor.author	Fikret Halis
dc.contributor.author	Sukru Kumsar
dc.contributor.author	Haci Ibrahim Cimen
dc.contributor.author	Gökçe, Ahmet